Home • Search • Translate
From Wikipedia, the free encyclopedia
Baicalein
Clinical data
Other namesBiacalein; Noroxylin
Identifiers
  • 5,6,7-trihydroxy-2-phenyl-4H-1-benzopyran-4-one
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard ( EPA)
ECHA InfoCard 100.164.911 Edit this at Wikidata
Chemical and physical data
FormulaC15H10O5
Molar mass270.240 g·mol−1
3D model ( JSmol)
  • O=C\1c3c(O)c(O)c(O)cc3O/C(=C/1)c2ccccc2
  • InChI=1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7,17-19H
  • Key:FXNFHKRTJBSTCS-UHFFFAOYSA-N

Baicalein (5,6,7-trihydroxyflavone) is a flavone, a type of flavonoid, [1] originally isolated from the roots of Scutellaria baicalensis and Scutellaria lateriflora. It is also a constituent of Oroxylum indicum (Indian trumpetflower) and thyme. [2] It is the aglycone of baicalin.

Pharmacology

Baicalein, along with its glucuronide baicalin, is a positive allosteric modulator of the benzodiazepine site and a non-benzodiazepine site of the GABAA receptor, but with an affinity over 250× lower than diazepam. [3] [4] [5] It displays subtype selectivity for α2 and α3 subunit-containing GABAA receptors. [6]

The flavonoid has been shown to inhibit certain types of lipoxygenases. [7]

Baicalein is an inhibitor of CYP2C9, [8] an enzyme of the cytochrome P450 system that metabolizes drugs in the body.

A derivative of baicalin is a known prolyl endopeptidase inhibitor. [9]

See also

References

  1. ^ "Flavonoids". Micronutrient Information Center, Linus Pauling Institute, Oregon State University. 2024. Retrieved 9 May 2024.
  2. ^ Matsumoto T (2008). Phytochemistry Research Progress. Nova Publishers. ISBN  9781604562323.
  3. ^ Zhang SQ, Obregon D, Ehrhart J, Deng J, Tian J, Hou H, et al. (September 2013). "Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse model". Journal of Neuroscience Research. 91 (9): 1239–1246. doi: 10.1002/jnr.23244. PMC  3810722. PMID  23686791.
  4. ^ Liao JF, Wang HH, Chen MC, Chen CC, Chen CF (August 1998). "Benzodiazepine binding site-interactive flavones from Scutellaria baicalensis root". Planta Medica. 64 (6): 571–572. doi: 10.1055/s-2006-957517. PMID  9776664. S2CID  260251315.
  5. ^ Roberts AA (2004). "Testing efficacy of natural anxiolytic compounds". In Cooper EL, Yamaguchi N (eds.). Complementary and Alternative Approaches to Biomedicine. Advances in Experimental Medicine and Biology. Vol. 546. pp. 181–191. doi: 10.1007/978-1-4757-4820-8_13. ISBN  978-1-4419-3441-3. PMID  15584374.
  6. ^ Wang F, Xu Z, Ren L, Tsang SY, Xue H (December 2008). "GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin". Neuropharmacology. 55 (7): 1231–1237. doi: 10.1016/j.neuropharm.2008.07.040. PMID  18723037. S2CID  20133964.
  7. ^ Deschamps JD, Kenyon VA, Holman TR (June 2006). "Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases". Bioorganic & Medicinal Chemistry. 14 (12): 4295–4301. doi: 10.1016/j.bmc.2006.01.057. PMID  16500106. S2CID  645610.
  8. ^ Si D, Wang Y, Zhou YH, Guo Y, Wang J, Zhou H, et al. (March 2009). "Mechanism of CYP2C9 inhibition by flavones and flavonols" (PDF). Drug Metabolism and Disposition. 37 (3): 629–634. doi: 10.1124/dmd.108.023416. PMID  19074529. S2CID  285706. Archived from the original (PDF) on 2008-12-17. Retrieved 2009-02-19.
  9. ^ Tarragó T, Kichik N, Claasen B, Prades R, Teixidó M, Giralt E (August 2008). "Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor". Bioorganic & Medicinal Chemistry. 16 (15): 7516–7524. doi: 10.1016/j.bmc.2008.04.067. PMID  18650094.
Retrieved from " https://en.wikipedia.org/?title=Baicalein&oldid=1223195750"

Top Of Page

Home • Search • Translate

© CSE